Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling
Xun Sun(Indiana University – Purdue University Indianapolis), Hiroki Yokota(Harbin Medical University)
Cited by 67
Related Papers
Effects of a checkpoint kinase inhibitor, AZD7762, on tumor suppression and bone remodeling
|International Journal of Oncology|2018|20